Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 77

1.

Pharmacologic Treatments and Supportive Care for Middle East Respiratory Syndrome.

Kain T, Lindsay PJ, Adhikari NKJ, Arabi YM, Van Kerkhove MD, Fowler RA.

Emerg Infect Dis. 2020 Mar 26;26(6). doi: 10.3201/eid2606.200037. [Epub ahead of print]

2.

Middle East respiratory syndrome.

Memish ZA, Perlman S, Van Kerkhove MD, Zumla A.

Lancet. 2020 Mar 28;395(10229):1063-1077. doi: 10.1016/S0140-6736(19)33221-0. Epub 2020 Mar 4. Review.

PMID:
32145185
3.

A database of geopositioned Middle East Respiratory Syndrome Coronavirus occurrences.

Ramshaw RE, Letourneau ID, Hong AY, Hon J, Morgan JD, Osborne JCP, Shirude S, Van Kerkhove MD, Hay SI, Pigott DM.

Sci Data. 2019 Dec 13;6(1):318. doi: 10.1038/s41597-019-0330-0.

4.

Middle East respiratory syndrome coronavirus (MERS-CoV) neutralising antibodies in a high-risk human population, Morocco, November 2017 to January 2018.

Abbad A, Perera RA, Anga L, Faouzi A, Minh NNT, Malik SMMR, Iounes N, Maaroufi A, Van Kerkhove MD, Peiris M, Nourlil J.

Euro Surveill. 2019 Nov;24(48). doi: 10.2807/1560-7917.ES.2019.24.48.1900244.

5.

A review of asymptomatic and sub-clinical Middle East Respiratory Syndrome Coronavirus Infections.

Grant R, Malik MR, Elkholy A, Van Kerkhove MD.

Epidemiol Rev. 2019 Nov 29. pii: mxz009. doi: 10.1093/epirev/mxz009. [Epub ahead of print]

6.

Transmissibility of MERS-CoV Infection in Closed Setting, Riyadh, Saudi Arabia, 2015.

Van Kerkhove MD, Alaswad S, Assiri A, Perera RAPM, Peiris M, El Bushra HE, BinSaeed AA.

Emerg Infect Dis. 2019 Oct;25(10):1802-1809. doi: 10.3201/eid2510.190130. Epub 2019 Oct 17.

7.

Worldwide Reduction in MERS Cases and Deaths since 2016.

Donnelly CA, Malik MR, Elkholy A, Cauchemez S, Van Kerkhove MD.

Emerg Infect Dis. 2019 Sep;25(9):1758-1760. doi: 10.3201/eid2509.190143. Epub 2019 Sep 17.

8.

A systematic review of MERS-CoV seroprevalence and RNA prevalence in dromedary camels: Implications for animal vaccination.

Dighe A, Jombart T, Van Kerkhove MD, Ferguson N.

Epidemics. 2019 Dec;29:100350. doi: 10.1016/j.epidem.2019.100350. Epub 2019 Jun 5.

9.

Comparative Analysis of Eleven Healthcare-Associated Outbreaks of Middle East Respiratory Syndrome Coronavirus (Mers-Cov) from 2015 to 2017.

Bernard-Stoecklin S, Nikolay B, Assiri A, Bin Saeed AA, Ben Embarek PK, El Bushra H, Ki M, Malik MR, Fontanet A, Cauchemez S, Van Kerkhove MD.

Sci Rep. 2019 May 14;9(1):7385. doi: 10.1038/s41598-019-43586-9.

10.

MERS-CoV infection among healthcare workers and risk factors for death: Retrospective analysis of all laboratory-confirmed cases reported to WHO from 2012 to 2 June 2018.

Elkholy AA, Grant R, Assiri A, Elhakim M, Malik MR, Van Kerkhove MD.

J Infect Public Health. 2020 Mar;13(3):418-422. doi: 10.1016/j.jiph.2019.04.011. Epub 2019 May 2.

11.

Qatar experience on One Health approach for middle-east respiratory syndrome coronavirus, 2012-2017: A viewpoint.

Farag E, Nour M, Islam MM, Mustafa A, Khalid M, Sikkema RS, Alhajri F, Bu-Sayaa A, Haroun M, Van Kerkhove MD, Elkholy A, Malik SMR, Reusken C, Koopmans M, AlHajri MM.

One Health. 2019 Apr 4;7:100090. doi: 10.1016/j.onehlt.2019.100090. eCollection 2019 Jun.

12.

An updated roadmap for MERS-CoV research and product development: focus on diagnostics.

Kelly-Cirino C, Mazzola LT, Chua A, Oxenford CJ, Van Kerkhove MD.

BMJ Glob Health. 2019 Feb 1;4(Suppl 2):e001105. doi: 10.1136/bmjgh-2018-001105. eCollection 2019.

13.

Reported Direct and Indirect Contact with Dromedary Camels among Laboratory-Confirmed MERS-CoV Cases.

Conzade R, Grant R, Malik MR, Elkholy A, Elhakim M, Samhouri D, Ben Embarek PK, Van Kerkhove MD.

Viruses. 2018 Aug 13;10(8). pii: E425. doi: 10.3390/v10080425.

14.

Current challenges and implications for dengue, chikungunya and Zika seroprevalence studies worldwide: A scoping review.

Fritzell C, Rousset D, Adde A, Kazanji M, Van Kerkhove MD, Flamand C.

PLoS Negl Trop Dis. 2018 Jul 16;12(7):e0006533. doi: 10.1371/journal.pntd.0006533. eCollection 2018 Jul. Review.

15.

Correction: Risk of bias and confounding of observational studies of Zika virus infection: A scoping review of research protocols.

Reveiz L, Haby MM, Martínez-Vega R, Pinzón-Flores CE, Elias V, Smith E, Pinart M, Broutet N, Becerra-Posada F, Aldighieri S, Van Kerkhove MD.

PLoS One. 2017 Nov 30;12(11):e0189027. doi: 10.1371/journal.pone.0189027. eCollection 2017.

16.

Risk of bias and confounding of observational studies of Zika virus infection: A scoping review of research protocols.

Reveiz L, Haby MM, Martínez-Vega R, Pinzón-Flores CE, Elias V, Smith E, Pinart M, Broutet N, Becerra-Posada F, Aldighieri S, Van Kerkhove MD.

PLoS One. 2017 Jul 7;12(7):e0180220. doi: 10.1371/journal.pone.0180220. eCollection 2017. Review. Erratum in: PLoS One. 2017 Nov 30;12 (11):e0189027.

17.

Key data for outbreak evaluation: building on the Ebola experience.

Cori A, Donnelly CA, Dorigatti I, Ferguson NM, Fraser C, Garske T, Jombart T, Nedjati-Gilani G, Nouvellet P, Riley S, Van Kerkhove MD, Mills HL, Blake IM.

Philos Trans R Soc Lond B Biol Sci. 2017 May 26;372(1721). pii: 20160371. doi: 10.1098/rstb.2016.0371. Review.

18.

Heterogeneities in the case fatality ratio in the West African Ebola outbreak 2013-2016.

Garske T, Cori A, Ariyarajah A, Blake IM, Dorigatti I, Eckmanns T, Fraser C, Hinsley W, Jombart T, Mills HL, Nedjati-Gilani G, Newton E, Nouvellet P, Perkins D, Riley S, Schumacher D, Shah A, Van Kerkhove MD, Dye C, Ferguson NM, Donnelly CA.

Philos Trans R Soc Lond B Biol Sci. 2017 May 26;372(1721). pii: 20160308. doi: 10.1098/rstb.2016.0308.

19.

A simple approach to measure transmissibility and forecast incidence.

Nouvellet P, Cori A, Garske T, Blake IM, Dorigatti I, Hinsley W, Jombart T, Mills HL, Nedjati-Gilani G, Van Kerkhove MD, Fraser C, Donnelly CA, Ferguson NM, Riley S.

Epidemics. 2018 Mar;22:29-35. doi: 10.1016/j.epidem.2017.02.012. Epub 2017 Feb 24.

20.

Middle East Respiratory Syndrome.

Arabi YM, Balkhy HH, Hayden FG, Bouchama A, Luke T, Baillie JK, Al-Omari A, Hajeer AH, Senga M, Denison MR, Nguyen-Van-Tam JS, Shindo N, Bermingham A, Chappell JD, Van Kerkhove MD, Fowler RA.

N Engl J Med. 2017 Feb 9;376(6):584-594. doi: 10.1056/NEJMsr1408795. No abstract available.

21.

Exposure Patterns Driving Ebola Transmission in West Africa: A Retrospective Observational Study.

International Ebola Response Team, Agua-Agum J, Ariyarajah A, Aylward B, Bawo L, Bilivogui P, Blake IM, Brennan RJ, Cawthorne A, Cleary E, Clement P, Conteh R, Cori A, Dafae F, Dahl B, Dangou JM, Diallo B, Donnelly CA, Dorigatti I, Dye C, Eckmanns T, Fallah M, Ferguson NM, Fiebig L, Fraser C, Garske T, Gonzalez L, Hamblion E, Hamid N, Hersey S, Hinsley W, Jambei A, Jombart T, Kargbo D, Keita S, Kinzer M, George FK, Godefroy B, Gutierrez G, Kannangarage N, Mills HL, Moller T, Meijers S, Mohamed Y, Morgan O, Nedjati-Gilani G, Newton E, Nouvellet P, Nyenswah T, Perea W, Perkins D, Riley S, Rodier G, Rondy M, Sagrado M, Savulescu C, Schafer IJ, Schumacher D, Seyler T, Shah A, Van Kerkhove MD, Wesseh CS, Yoti Z.

PLoS Med. 2016 Nov 15;13(11):e1002170. doi: 10.1371/journal.pmed.1002170. eCollection 2016 Nov.

22.

Harmonisation of Zika virus research protocols to address key public health concerns.

Van Kerkhove MD, Reveiz L, Souza JP, Jaenisch T, Carson G, Broutet N; Working Group on ZIKV Harmonized Research.

Lancet Glob Health. 2016 Dec;4(12):e911-e912. doi: 10.1016/S2214-109X(16)30255-8. Epub 2016 Nov 1. No abstract available.

23.

Environmental contamination and risk factors for transmission of highly pathogenic avian influenza A(H5N1) to humans, Cambodia, 2006-2010.

Ly S, Vong S, Cavailler P, Mumford E, Mey C, Rith S, Van Kerkhove MD, Sorn S, Sok T, Tarantola A, Buchy P.

BMC Infect Dis. 2016 Nov 4;16(1):631.

24.

MERS-CoV at the Animal-Human Interface: Inputs on Exposure Pathways from an Expert-Opinion Elicitation.

Funk AL, Goutard FL, Miguel E, Bourgarel M, Chevalier V, Faye B, Peiris JS, Van Kerkhove MD, Roger FL.

Front Vet Sci. 2016 Oct 5;3:88. eCollection 2016.

25.

After Ebola in West Africa--Unpredictable Risks, Preventable Epidemics.

WHO Ebola Response Team, Agua-Agum J, Allegranzi B, Ariyarajah A, Aylward R, Blake IM, Barboza P, Bausch D, Brennan RJ, Clement P, Coffey P, Cori A, Donnelly CA, Dorigatti I, Drury P, Durski K, Dye C, Eckmanns T, Ferguson NM, Fraser C, Garcia E, Garske T, Gasasira A, Gurry C, Hamblion E, Hinsley W, Holden R, Holmes D, Hugonnet S, Jaramillo Gutierrez G, Jombart T, Kelley E, Santhana R, Mahmoud N, Mills HL, Mohamed Y, Musa E, Naidoo D, Nedjati-Gilani G, Newton E, Norton I, Nouvellet P, Perkins D, Perkins M, Riley S, Schumacher D, Shah A, Tang M, Varsaneux O, Van Kerkhove MD.

N Engl J Med. 2016 Aug 11;375(6):587-96. doi: 10.1056/NEJMsr1513109. No abstract available.

26.

Unraveling the drivers of MERS-CoV transmission.

Cauchemez S, Nouvellet P, Cori A, Jombart T, Garske T, Clapham H, Moore S, Mills HL, Salje H, Collins C, Rodriquez-Barraquer I, Riley S, Truelove S, Algarni H, Alhakeem R, AlHarbi K, Turkistani A, Aguas RJ, Cummings DA, Van Kerkhove MD, Donnelly CA, Lessler J, Fraser C, Al-Barrak A, Ferguson NM.

Proc Natl Acad Sci U S A. 2016 Aug 9;113(32):9081-6. doi: 10.1073/pnas.1519235113. Epub 2016 Jul 25.

27.

Interpreting Results From Environmental Contamination Studies of Middle East Respiratory Syndrome Coronavirus.

Van Kerkhove MD, Peiris MJ, Malik MR, Ben Embarek P.

Clin Infect Dis. 2016 Oct 15;63(8):1142. doi: 10.1093/cid/ciw478. Epub 2016 Jul 17. No abstract available.

28.

CONSISE statement on the reporting of Seroepidemiologic Studies for influenza (ROSES-I statement): an extension of the STROBE statement.

Horby PW, Laurie KL, Cowling BJ, Engelhardt OG, Sturm-Ramirez K, Sanchez JL, Katz JM, Uyeki TM, Wood J, Van Kerkhove MD; CONSISE Steering Committee.

Influenza Other Respir Viruses. 2017 Jan;11(1):2-14. doi: 10.1111/irv.12411. Epub 2016 Aug 9.

29.

The search for therapeutic options for Middle East Respiratory Syndrome (MERS).

Arabi YM, Balkhy HH, Hayden FG, Hui DS, Van Kerkhove MD, Fowler RA.

J Infect Public Health. 2016 May-Jun;9(3):213-5. doi: 10.1016/j.jiph.2016.03.004. Epub 2016 Mar 31. No abstract available.

30.

Association between Zika virus and microcephaly in French Polynesia, 2013-15: a retrospective study.

Cauchemez S, Besnard M, Bompard P, Dub T, Guillemette-Artur P, Eyrolle-Guignot D, Salje H, Van Kerkhove MD, Abadie V, Garel C, Fontanet A, Mallet HP.

Lancet. 2016 May 21;387(10033):2125-2132. doi: 10.1016/S0140-6736(16)00651-6. Epub 2016 Mar 16.

31.

Knowledge gaps in therapeutic and non-therapeutic research on the Middle East respiratory syndrome.

Arabi YM, Fowler R, Bright RA, Van Kerkhove MD, Balkhy HH.

Lancet Respir Med. 2016 Feb;4(2):93-4. doi: 10.1016/S2213-2600(16)00007-2. No abstract available.

PMID:
26868624
32.

Estimating the Severity and Subclinical Burden of Middle East Respiratory Syndrome Coronavirus Infection in the Kingdom of Saudi Arabia.

Lessler J, Salje H, Van Kerkhove MD, Ferguson NM, Cauchemez S, Rodriquez-Barraquer I, Hakeem R, Jombart T, Aguas R, Al-Barrak A, Cummings DA; MERS-CoV Scenario and Modeling Working Group.

Am J Epidemiol. 2016 Apr 1;183(7):657-63. doi: 10.1093/aje/kwv452. Epub 2016 Feb 4.

33.

Ebola Virus Disease among Male and Female Persons in West Africa.

WHO Ebola Response Team, Agua-Agum J, Ariyarajah A, Blake IM, Cori A, Donnelly CA, Dorigatti I, Dye C, Eckmanns T, Ferguson NM, Fraser C, Garske T, Hinsley W, Jombart T, Mills HL, Nedjati-Gilani G, Newton E, Nouvellet P, Perkins D, Riley S, Schumacher D, Shah A, Thomas LJ, Van Kerkhove MD.

N Engl J Med. 2016 Jan 7;374(1):96-8. doi: 10.1056/NEJMc1510305. No abstract available.

34.

The role of rapid diagnostics in managing Ebola epidemics.

Nouvellet P, Garske T, Mills HL, Nedjati-Gilani G, Hinsley W, Blake IM, Van Kerkhove MD, Cori A, Dorigatti I, Jombart T, Riley S, Fraser C, Donnelly CA, Ferguson NM.

Nature. 2015 Dec 3;528(7580):S109-16. doi: 10.1038/nature16041.

35.

Risk factors for severe outcomes among members of the United States military hospitalized with pneumonia and influenza, 2000-2012.

Van Kerkhove MD, Cooper MJ, Cost AA, Sanchez JL, Riley S.

Vaccine. 2015 Dec 8;33(49):6970-6. doi: 10.1016/j.vaccine.2015.09.115. Epub 2015 Oct 20.

36.

Potential Biases in Estimating Absolute and Relative Case-Fatality Risks during Outbreaks.

Lipsitch M, Donnelly CA, Fraser C, Blake IM, Cori A, Dorigatti I, Ferguson NM, Garske T, Mills HL, Riley S, Van Kerkhove MD, Hernán MA.

PLoS Negl Trop Dis. 2015 Jul 16;9(7):e0003846. doi: 10.1371/journal.pntd.0003846. eCollection 2015. Review.

37.

International Laboratory Comparison of Influenza Microneutralization Assays for A(H1N1)pdm09, A(H3N2), and A(H5N1) Influenza Viruses by CONSISE.

Laurie KL, Engelhardt OG, Wood J, Heath A, Katz JM, Peiris M, Hoschler K, Hungnes O, Zhang W, Van Kerkhove MD; CONSISE Laboratory Working Group participants.

Clin Vaccine Immunol. 2015 Aug;22(8):957-64. doi: 10.1128/CVI.00278-15. Epub 2015 Jun 24.

38.

A review of epidemiological parameters from Ebola outbreaks to inform early public health decision-making.

Van Kerkhove MD, Bento AI, Mills HL, Ferguson NM, Donnelly CA.

Sci Data. 2015 May 26;2:150019. doi: 10.1038/sdata.2015.19. eCollection 2015.

39.

Middle East respiratory syndrome coronavirus (MERS-CoV): current situation 3 years after the virus was first identified.

Ben Embarek PK, Van Kerkhove MD.

Wkly Epidemiol Rec. 2015 May 15;90(20):245-50. English, French. No abstract available.

40.

Ebola virus disease among children in West Africa.

WHO Ebola Response Team, Agua-Agum J, Ariyarajah A, Blake IM, Cori A, Donnelly CA, Dorigatti I, Dye C, Eckmanns T, Ferguson NM, Fowler RA, Fraser C, Garske T, Hinsley W, Jombart T, Mills HL, Murthy S, Nedjati Gilani G, Nouvellet P, Pelletier L, Riley S, Schumacher D, Shah A, Van Kerkhove MD.

N Engl J Med. 2015 Mar 26;372(13):1274-7. doi: 10.1056/NEJMc1415318. No abstract available.

41.

West African Ebola epidemic after one year--slowing but not yet under control.

WHO Ebola Response Team, Agua-Agum J, Ariyarajah A, Aylward B, Blake IM, Brennan R, Cori A, Donnelly CA, Dorigatti I, Dye C, Eckmanns T, Ferguson NM, Formenty P, Fraser C, Garcia E, Garske T, Hinsley W, Holmes D, Hugonnet S, Iyengar S, Jombart T, Krishnan R, Meijers S, Mills HL, Mohamed Y, Nedjati-Gilani G, Newton E, Nouvellet P, Pelletier L, Perkins D, Riley S, Sagrado M, Schnitzler J, Schumacher D, Shah A, Van Kerkhove MD, Varsaneux O, Wijekoon Kannangarage N.

N Engl J Med. 2015 Feb 5;372(6):584-7. doi: 10.1056/NEJMc1414992. Epub 2014 Dec 24. No abstract available.

42.

Ebola virus disease in West Africa--the first 9 months of the epidemic and forward projections.

WHO Ebola Response Team, Aylward B, Barboza P, Bawo L, Bertherat E, Bilivogui P, Blake I, Brennan R, Briand S, Chakauya JM, Chitala K, Conteh RM, Cori A, Croisier A, Dangou JM, Diallo B, Donnelly CA, Dye C, Eckmanns T, Ferguson NM, Formenty P, Fuhrer C, Fukuda K, Garske T, Gasasira A, Gbanyan S, Graaff P, Heleze E, Jambai A, Jombart T, Kasolo F, Kadiobo AM, Keita S, Kertesz D, Koné M, Lane C, Markoff J, Massaquoi M, Mills H, Mulba JM, Musa E, Myhre J, Nasidi A, Nilles E, Nouvellet P, Nshimirimana D, Nuttall I, Nyenswah T, Olu O, Pendergast S, Perea W, Polonsky J, Riley S, Ronveaux O, Sakoba K, Santhana Gopala Krishnan R, Senga M, Shuaib F, Van Kerkhove MD, Vaz R, Wijekoon Kannangarage N, Yoti Z.

N Engl J Med. 2014 Oct 16;371(16):1481-95. doi: 10.1056/NEJMoa1411100. Epub 2014 Sep 22.

43.

Yellow Fever in Africa: estimating the burden of disease and impact of mass vaccination from outbreak and serological data.

Garske T, Van Kerkhove MD, Yactayo S, Ronveaux O, Lewis RF, Staples JE, Perea W, Ferguson NM; Yellow Fever Expert Committee.

PLoS Med. 2014 May 6;11(5):e1001638. doi: 10.1371/journal.pmed.1001638. eCollection 2014 May.

44.

School closures during the 2009 influenza pandemic: national and local experiences.

Cauchemez S, Van Kerkhove MD, Archer BN, Cetron M, Cowling BJ, Grove P, Hunt D, Kojouharova M, Kon P, Ungchusak K, Oshitani H, Pugliese A, Rizzo C, Saour G, Sunagawa T, Uzicanin A, Wachtel C, Weisfuse I, Yu H, Nicoll A.

BMC Infect Dis. 2014 Apr 16;14:207. doi: 10.1186/1471-2334-14-207.

45.

Identification of MERS-CoV in dromedary camels.

Ferguson NM, Van Kerkhove MD.

Lancet Infect Dis. 2014 Feb;14(2):93-4. doi: 10.1016/S1473-3099(13)70691-1. Epub 2013 Dec 17. No abstract available.

PMID:
24355867
46.

Global mortality estimates for the 2009 Influenza Pandemic from the GLaMOR project: a modeling study.

Simonsen L, Spreeuwenberg P, Lustig R, Taylor RJ, Fleming DM, Kroneman M, Van Kerkhove MD, Mounts AW, Paget WJ; GLaMOR Collaborating Teams.

PLoS Med. 2013 Nov;10(11):e1001558. doi: 10.1371/journal.pmed.1001558. Epub 2013 Nov 26.

47.

Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility.

Cauchemez S, Fraser C, Van Kerkhove MD, Donnelly CA, Riley S, Rambaut A, Enouf V, van der Werf S, Ferguson NM.

Lancet Infect Dis. 2014 Jan;14(1):50-56. doi: 10.1016/S1473-3099(13)70304-9. Epub 2013 Nov 13.

48.

Incidence of influenza A(H1N1)pdm09 infection, United Kingdom, 2009-2011.

Sridhar S, Begom S, Bermingham A, Hoschler K, Adamson W, Carman W, Van Kerkhove MD, Lalvani A.

Emerg Infect Dis. 2013 Nov;19(11):1866-9. doi: 10.3201/eid1911.130295.

49.

Brief literature review for the WHO global influenza research agenda--highly pathogenic avian influenza H5N1 risk in humans.

Van Kerkhove MD.

Influenza Other Respir Viruses. 2013 Sep;7 Suppl 2:26-33. doi: 10.1111/irv.12077. Review.

50.

Multiple contributory factors to the age distribution of disease cases: a modeling study in the context of influenza A(H3N2v).

Gambhir M, Swerdlow DL, Finelli L, Van Kerkhove MD, Biggerstaff M, Cauchemez S, Ferguson NM.

Clin Infect Dis. 2013 Jul;57 Suppl 1:S23-7. doi: 10.1093/cid/cit298.

Supplemental Content

Loading ...
Support Center